Skip to main content

Pfizer earnings: Looking toward an ambitious 2022 agenda

Pfizer plans to have up to 30 new drug approvals in the coming years, to make up for losing patent protection on a number of valuable products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.